Table 2. Univariate and Multivariate Analyses of Variables Influencing Survival of 288 Patients with HCC.
| Characteristics | Univariate Analysis |
Multivariate Analysis |
||||
|---|---|---|---|---|---|---|
| N (%) | P-Value | β | Exp (β) | 95% CI for Exp (β) | P-Value | |
| Gender | 0.908 | – | – | – | – | |
| Male | 230 (79.9) | |||||
| Female | 58 (20.1) | |||||
| Age, years | 0.842 | – | – | – | – | |
| <50 | 61 (21.2) | |||||
| ≥50 | 227 (78.8) | |||||
| Child-Pugh stage | 0.126 | – | – | – | – | |
| A | 242 (84.0) | |||||
| B | 46 (16.0) | |||||
| Serum AFP | 214 (74.3) | <0.001 | −0.493 | 0.611 | 0.001 | |
| <200μg/L | 74 (25.7) | 0.457–0.817 | ||||
| >200μg/L | ||||||
| TACE | <0.001 | 0.597 | 1.816 | <0.001 | ||
| Yes | 113 (39.2) | 1.362–2.421 | ||||
| No | 175 (60.8) | |||||
| Palliative Surgery | 0.001 | 0.460 | 1.584 | 0.006 | ||
| Yes | 57 (19.8) | 1.142–2.198 | ||||
| No | 231 (80.2) | |||||
| Systemic Chemotherapy | 0.064 | – | – | – | – | |
| Yes | 28 (9.7) | |||||
| No | 260 (90.3) | |||||
| Clinical Stage Composition | <0.001 | −1.072 | 0.342 | <0.001 | ||
| III | 197 (68.4) | 0.247–0.474 | ||||
| IV | 91 (31.6) | |||||
| TCM | <0.001 | 0.845 | 2.328 | <0.001 | ||
| Yes | 115 (39.9) | 1.796–3.017 | ||||
| No | 173 (60.1) | |||||
P-values in bold font are statistically significant. TACE: Transcatheter arterial chemoembolization; AFP: Alpha-fetoprotein; CI: confidence interval; TCM: Traditional Chinese medicine.